Growth Metrics

Fennec Pharmaceuticals (FENC) Enterprise Value (2010 - 2025)

Fennec Pharmaceuticals posted quarterly Enterprise Value of -$36.8 million for Q4 2025, down 38.12% year-on-year from -$59.5 million in Q4 2024, and down 67.62% on a QoQ basis from -$21.9 million in Q3 2025.

Fennec Pharmaceuticals (FENC) has 16 years of Enterprise Value data on file, last reported at -$36.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value fell 38.12% year-over-year to -$36.8 million; the trailing twelve-month figure through Dec 2025 stood at -$36.8 million (down 38.12% YoY), and the FY2025 full-year result was -$36.8 million, down 38.12% from the prior year.
  • Enterprise Value for Q4 2025 stood at -$36.8 million, down from -$21.9 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$12.4 million in Q3 2023 and bottomed at -$51.2 million in Q1 2024.
  • The 5-year median for Enterprise Value is -$23.2 million (2022), against an average of -$25.1 million.
  • The widest annual swing landed in 2023, when Enterprise Value jumped 58.33%; it then slumped 285.74% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$21.1 million in 2021, then fell by 12.67% to -$23.8 million in 2022, then surged by 44.19% to -$13.3 million in 2023, then sank by 100.72% to -$26.6 million in 2024, then slumped by 38.12% to -$36.8 million in 2025.
  • The last three Enterprise Value figures came in at -$36.8 million (Q4 2025), -$21.9 million (Q3 2025), and -$18.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.32 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -7.25 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.75 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -3.01 Bn
10 Fennec Pharmaceuticals 281.48 Mn 244.70 Mn 7.67 Mn -36.79 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -36.79 Mn
Sep 30, 2025 -21.95 Mn
Jun 30, 2025 -18.71 Mn
Mar 31, 2025 -22.68 Mn
Dec 31, 2024 -26.63 Mn
Sep 30, 2024 -40.32 Mn
Jun 30, 2024 -43.05 Mn
Mar 31, 2024 -51.18 Mn
Dec 31, 2023 -13.27 Mn
Sep 30, 2023 -12.40 Mn
Jun 30, 2023 -14.96 Mn
Mar 31, 2023 -13.27 Mn
Dec 31, 2022 -23.77 Mn
Sep 30, 2022 -29.75 Mn
Jun 30, 2022 -14.92 Mn
Mar 31, 2022 -18.26 Mn
Dec 31, 2021 -21.10 Mn
Sep 30, 2021 -24.34 Mn
Jun 30, 2021 -27.29 Mn
Mar 31, 2021 -26.75 Mn
Dec 31, 2020 -30.34 Mn
Sep 30, 2020 -33.17 Mn
Jun 30, 2020 -38.73 Mn
Mar 31, 2020 -9.90 Mn
Dec 31, 2019 -13.65 Mn
Sep 30, 2019 -15.24 Mn
Jun 30, 2019 -13.65 Mn
Mar 31, 2019 -20.23 Mn
Dec 31, 2018 -22.78 Mn
Sep 30, 2018 -24.52 Mn
Jun 30, 2018 -25.64 Mn
Mar 31, 2018 -26.72 Mn
Dec 31, 2017 -28.26 Mn
Sep 30, 2017 -9.69 Mn
Jun 30, 2017 -10.23 Mn
Mar 31, 2017 -3.25 Mn
Dec 31, 2016 -3.93 Mn
Sep 30, 2016 -4.54 Mn
Jun 30, 2016 -5.08 Mn
Mar 31, 2016 -545,000.00
Dec 31, 2015 -942,000.00
Sep 30, 2015 -1.37 Mn
Jun 30, 2015 -1.85 Mn
Mar 31, 2015 -1.92 Mn
Dec 31, 2014 -2.31 Mn
Sep 30, 2014 -593,000.00
Jun 30, 2014 -1.02 Mn
Mar 31, 2014 -1.34 Mn
Dec 31, 2013 -1.66 Mn
Sep 30, 2013 -538,000.00
Jun 30, 2013 -1.01 Mn
Mar 31, 2013 -1.90 Mn
Dec 31, 2012 -2.30 Mn
Sep 30, 2012 -2.86 Mn
Jun 30, 2012 -3.59 Mn
Mar 31, 2012 -4.72 Mn
Dec 31, 2011 -5.30 Mn
Sep 30, 2011 -6.17 Mn
Jun 30, 2011 -6.81 Mn
Mar 31, 2011 -5.02 Mn
Dec 31, 2010 -5.95 Mn
Sep 30, 2010 -6.60 Mn
Jun 30, 2010 -7.15 Mn